TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases

BioEssays

Volumn 27, Issue 11, 2005, Pages 1147-1157

  Meroni, Germana ^a   Diez Roux, Graciana ^a  

^a TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN RBCC; PROTEIN TRIM; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

APOPTOSIS; BIOCHEMISTRY; CELL CYCLE; NONHUMAN; PATHOLOGICAL ANATOMY; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN MOTIF; REVIEW; RING DOMAIN; UBIQUITINATION; VIRUS CELL INTERACTION;

ANIMALS; CARRIER PROTEINS; EVOLUTION, MOLECULAR; HUMANS; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 30444452500     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.20304     Document Type: Review

References (106)

1. Torok M, Etkin LD. 2001. Two B or not two B? Overview of the rapidly expanding B-box family of proteins. Differentiation 67:63-71.
2. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, et al. 2001. The tripartite motif family identifies cell compartments. Embo J 20:2140-2151.
3. Glickman MH, Ciechanover A. 2002. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82:373-428.
4. Hicke L, Dunn R. 2003. Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins. Annu Rev Cell Dev Biol 19:141-172.
5. Di Fiore PP, Polo S, Hofmann K. 2003. When ubiquitin meets ubiquitin receptors: a signaling connection. Nat Rev Mol Cell Biol 4:491-497.
6. Weissman AM. 2001. Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol 2:169-178.
7. Schwartz DC, Hochstrasser M. 2003. A superfamily of protein tags: ubiquitin, SUMO and related modifiers. Trends Biochem Sci 28:321-328.
8. Freemont PS. 1993. The RING finger. A novel protein sequence motif related to the zinc finger. Ann N Y Acad Sci 684:174-192.
9. Barlow PN, Luisi B, Milner A, Elliott M, Everett R. 1994. Structure of the C3HC4 domain by 1H-nuclear magnetic resonance spectroscopy. A new structural class of zinc-finger. J Mol Biol 237:201-211.
10. Borden KL, Boddy MN, Lally J, O'Reilly NJ, Martin S, et al. 1995. The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto-oncoprotein PML. Embo J 14:1532-1541.
11. Freemont PS. 2000. RING for destruction? Curr Biol 10:R84-87.
12. Joazeiro CA, Weissman AM. 2000. RING finger proteins: mediators of ubiquitin ligase activity. Cell 102:549-552.
13. Borden KL, Martin SR, O'Reilly NJ, Lally JM, Reddy BA, et al. 1993. Characterisation of a novel cysteine/histidine-rich metal binding domain from Xenopus nuclear factor XNF7. FEBS Lett 335:255-260.
14. Borden KL, Lally JM, Martin SR, O'Reilly NJ, Etkin LD, et al. 1995. Novel topology of a zinc-binding domain from a protein involved in regulating early Xenopus development. Embo J 14:5947-5956.
15. Lupas A. 1996. Coiled coils: new structures and new functions. Trends in Biochemical Sciences 21:375-382.
16. Henry J, Mather IH, McDermott MF, Pontarotti P. 1998. B30.2-like domain proteins: update and new insights into a rapidly expanding family of proteins. Mol Biol Evol 15:1696-1705.
17. Slack FJ, Ruvkun G. 1998. A novel repeat domain that is often associated with RING finger and B- box motifs. Trends Biochem Sci 23:474-475.
18. Peng H, Feldman I, Rauscher FJ 3rd. 2002. Hetero-oligomerization among the TIF family of RBCC/TRIM domain-containing nuclear cofactors: a potential mechanism for regulating the switch between coactivation and corepression. J Mol Biol 320:629-644.
19. Meyer M, Gaudieri S, Rhodes DA, Trowsdale J. 2003. Cluster of TRIM genes in the human MHC class I region sharing the B30.2 domain. Tissue Antigens 61:63-71.
20. Jackson PK, Eldridge AG, Freed E, Furstenthal L, Hsu JY, et al. 2000. The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases. Trends Cell Biol 10:429-439.
21. Pickart CM, Eddins MJ. 2004. Ubiquitin: structures, functions, mechanisms. Biochim Biophys Acta 1695:55-72.
22. Urano T, Saito T, Tsukui T, Fujita M, Hosoi T, et al. 2002. Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. Nature 417:871-875.
23. Trockenbacher A, Suckow V, Foerster J, Winter J, Krauss S, et al. 2001. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat Genet 29:287-294.
24. Liu J, Prickett TD, Elliott E, Meroni G, Brautigan DL. 2001. Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4. Proc Natl Acad Sci USA 98:6650-6655.
25. Dupont S, Zacchigna L, Cordenonsi M, Soligo S, Adorno M, et al. 2005. Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell 121:87-99.
26. Toniato E, Chen XP, Losman J, Flati V, Donahue L, et al. 2002. TRIM8/GERP RING finger protein interacts with SOCS-1. J Biol Chem 277:37315-37322.
27. Niikura T, Hashimoto Y, Tajima H, Ishizaka M, Yamagishi Y, et al. 2003. A tripartite motif protein TRIM11 binds and destabilizes Humanin, a neuroprotective peptide against Alzheimer's disease-relevant insults. Eur J Neurosci 17:1150-1158.
28. McElhinny AS, Kakinuma K, Sorimachi H, Labeit S, Gregorio CC. 2002. Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1. J Cell Biol 157:125-136.
29. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, et al. 2001. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294:1704-1708.
30. Xu L, Yang L, Moitra PK, Hashimoto K, Rallabhandi P, et al. 2003. BTBD1 and BTBD2 colocalize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5delta. Exp Cell Res 288:84-93.
31. Miyamoto K, Nakamura N, Kashiwagi M, Honda S, Kato A, et al. 2002. RING finger, B-box, and coiled-coil (RBCC) protein expression in branchial epithelial cells of Japanese eel, Anguilla japonica. Eur J Biochem 269:6152-6161.
32. Horn EJ, Albor A, Liu Y, El-Hizawi S, Vanderbeek GE, et al. 2004. RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties. Carcinogenesis 25:157-167.
33. Lorick KL, Jensen JP, Fang S, Ong AM, Hatakeyama S, et al. 1999. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc Natl Acad Sci USA 96:11364-11369.
34. Zheng N, Wang P, Jeffrey PD, Pavletich NP. 2000. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 102:533-539.
35. Peng H, Begg GE, Schultz DC, Friedman JR, Jensen DE, et al. 2000. Reconstitution of the KRAB-KAP-1 repressor complex: a model system for defining the molecular anatomy of RING-B box-coiled-coil domain-mediated protein-protein interactions. J Mol Biol 295:1139-1162.
36. Fagioli M, Alcalay M, Tomassoni L, Ferrucci PF, Mencarelli A, et al. 1998. Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival. Oncogene 16:2905-2913.
37. Kimura F, Suzu S, Nakamura Y, Nakata Y, Yamada M, et al. 2003. Cloning and characterization of a novel RING-B-box-coiled-coil protein with apoptotic function. J Biol Chem 278:25046-25054.
38. Cao T, Borden KL, Freemont PS, Etkin LD. 1997. Involvement of the rfp tripartite motif in protein-protein interactions and subcellular distribution. J Cell Sci 110:1563-1571.
39. Suzumori N, Burns KH, Yan W, Matzuk MM. 2003. RFPL4 interacts with oocyte proteins of the ubiquitin-proteasome degradation pathway. Proc Natl Acad Sci USA 100:550-555.
40. Lu Z, Xu S, Joazeiro C, Cobb MH, Hunter T. 2002. The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2. Mol Cell 9:945-956.
41. Hodges M, Tissot C, Howe K, Grimwade D, Freemont PS. 1998. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. Am J Hum Genet 63:297-304.
42. Cao T, Duprez E, Borden KL, Freemont PS, Etkin LD. 1998. Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML. J Cell Sci 111:1319-1329.
43. Short KM, Hopwood B, Yi Z, Cox TC. 2002. MID1 and MID2 homo- and heterodimerise to tether the rapamycin- sensitive PP2A regulatory subunit, Alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders. BMC Cell Biol 3:1.
44. Zhong S, Delva L, Rachez C, Cenciarelli C, Gandini D, et al. 1999. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins. Nat Genet 23:287-295.
45. Fanelli M, Fantozzi A, De Luca P, Caprodossi S, Matsuzawa S, et al. 2004. The coiled-coil domain is the structural determinant for mammalian homologues of Drosophila Sina-mediated degradation of promyelocytic leukemia protein and other tripartite motif proteins by the proteasome. J Biol Chem 279:5374-5379.
46. Aguilar RC, Wendland B. 2003. Ubiquitin: not just for proteasomes anymore. Curr Opin Cell Biol 15:184-190.
47. Gill G. 2004. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev 18:2046-2059.
48. Jensen K, Shiels C, Freemont PS. 2001. PML protein isoforms and the RBCC/TRIM motif. Oncogene 20:7223-7233.
49. Pearson M, Pelicci PG. 2001. PML interaction with p53 and its role in apoptosis and replicative senescence. Oncogene 20:7250-7256.
50. Seeler JS, Dejean A. 2001. SUMO: of branched proteins and nuclear bodies. Oncogene 20:7243-7249.
51. Hay RT. 2005. SUMO: a history of modification. Mol Cell 18:1-12.
52. Muller S, Hoege C, Pyrowolakis G, Jentsch S. 2001. SUMO, ubiquitin's mysterious cousin. Nat Rev Mol Cell Biol 2:202-210.
53. Duprez E, Saurin AJ, Desterro JM, Lallemand-Breitenbach V, Howe K, et al. 1999. SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J Cell Sci 112:381-393.
54. Boddy MN, Howe K, Etkin LD, Solomon E, Freemont PS. 1996. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene 13:971-982.
55. Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, et al. 1999. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 147:221-234.
56. Gostissa M, Hengstermann A, Fogal V, Sandy P, Schwarz SE, et al. 1999. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. Embo J 18:6462-6471.
57. Dai KS, Liew CC. 2001. A novel human striated muscle RING zinc finger protein, SMRZ, interacts with SMTSb via its RING domain. J Biol Chem 276:23992-23999.
58. Conaway RC, Brower CS, Conaway JW. 2002. Emerging roles of ubiquitin in transcription regulation. Science 296:1254-1258.
59. Le Douarin B, Nielsen AL, Garnier JM, lchinose H, Jeanmougin F, et al. 1996. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. Embo J 15:6701-6715.
60. Shimono Y, Murakami H, Hasegawa Y, Takahashi M. 2000. RET finger protein is a transcriptional represser and interacts with enhancer of polycomb that has dual transcriptional functions. J Biol Chem 275:39411-39419.
61. Kallijarvi J, Avela K, Lipsanen-Nyman M, Ulmanen I, Lehesjoki AE. 2002. The TRIM37 gene encodes a peroxisomal RING-B-box-coiled-coil protein: classification of mulibrey nanism as a new peroxisomal disorder. Am J Hum Genet 70:1215-12128.
62. Vitale N, Horiba K, Ferrans VJ, Moss J, Vaughan M. 1998. Localization of ADP-ribosylation factor domain protein 1 (ARD1) in lysosomes and Golgi apparatus. Proc Natl Acad Sci USA 95:8613-8618.
63. Li Y, Chin LS, Weigel C, Li L. 2001. Spring, a novel RING finger protein that regulates synaptic vesicle exocytosis. J Biol Chem 276:40824-40833.
64. Quaderi NA, Schweiger S, Gaudenz K, Franco B, Rugarli EI, et al. 1997. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nature Genetics 17:285-291.
65. Cainarca S, Messali S, Ballabio A, Meroni G. 1999. Functional characterization of the Opitz syndrome gene product (midin): evidence for homodimerization and association with microtubules throughout the cell cycle. Hum Mol Genet 8:1387-1396.
66. Schweiger S, Foerster J, Lehmann T, Suckow V, Muller YA, et al. 1999. The Opitz syndrome gene product, MID1, associates with microtubules. Proc Natl Acad Sci USA 96:2794-2799.
67. Ikeda K, Orimo A, Higashi Y, Muramatsu M, lnoue S. 2000. Efp as a primary estrogen-responsive gene in human breast cancer. FEBS Lett 472:9-13.
68. Frosk P, Weiler T, Nylen E, Sudha T, Greenberg CR, et al. 2002. Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am J Hum Genet 70:663-672.
69. Avela K, Lipsanen-Nyman M, ldanheimo N, Seemanova E, Rosengren S, et al. 2000. Gene encoding a new RING-B-box-coiled-coil protein is mutated in mulibrey nanism [In Process Citation]. Nat Genet 25:298-301.
70. FMF International Consortium. 1997. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90:797-807.
71. FMF Franch Consortium. 1997. A candidate gene for familial Mediterranean fever. Nat Genet 17:25-31.
72. Harley JB, Alexander EL, Bias WB, Fox OF, Provost TT, et al. 1986. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjogren's syndrome. Arthritis Rheum 29:196-206.
73. Billaut-Mulot O, Cocude C, Kolesnitchenko V, Truong MJ, Chan EK, et al. 2001. SS-56, a novel cellular target of autoantibody responses in Sjogren syndrome and systemic lupus erythematosus. J Clin Invest 108:861-869.
74. de The H, Lavau C, Marchio A, Chomienne C, Degos L, et al. 1991. The PML-RAR alpha fusion mRNA generated by the t(15:17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675-684.
75. Takahashi M, Inaguma Y, Hiai H, Hirose F. 1988. Developmentally regulated expression of a human "finger"-containing gene encoded by the 5′ half of the ret transforming gene. Mol Cell Biol 8:1853-1856.
76. Klugbauer S, Rabes HM. 1999. The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas. Oncogene 18:4388-4393.
77. Le Douarin B, Zechel C, Garnier JM, Lutz Y, Tora L, et al. 1995. The N-terminal part of TIF1, a putative mediator of the ligand- dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. Embo J 14:2020-2033.
78. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, et al. 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427:848-853.
79. Yap MW, Nisole S, Lynch C, Stoye JP. 2004. Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci USA 101:10786-10791.
80. Regad T, Chelbi-Alix MK. 2001. Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 20:7274-7286.
81. Tissot C, Mechti N. 1995. Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J Biol Chem 270:14891-14898.
82. Patarca R, Freeman GJ, Schwartz J, Singh RP, Kong QT, et al. 1988. rpt-1, an intracellular protein from helper/inducer T cells that regulates gene expression of interleukin 2 receptor and human immunodeficiency virus type 1. Proc Natl Acad Sci USA 85:2733-2737.
83. Orimo A, Tominaga N, Yoshimura K, Yamauchi Y, Nomura M, et al. 2000. Molecular cloning of ring finger protein 21 (RNF21)/interferon-responsive finger protein (ifp1), which possesses two RING-B box-coiled coil domains in tandem. Genomics 69:143-149.
84. Turelli P, Doucas V, Craig E, Mangeat B, Klages N, et al. 2001. Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol Cell 7:1245-1254.
85. Negorev D, Maul GG. 2001. Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene 20:7234-7242.
86. Salomoni P, Pandolfi PP. 2002. The role of PML in tumor suppression. Cell 108:165-170.
87. Ohkawa N, Kokura K, Matsu-Ura T, Obinata T, Konishi Y, et al. 2001. Molecular cloning and characterization of neural activity-related RING finger protein (NARF): a new member of the RBCC family is a candidate for the partner of myosin V. J Neurochem 78:75-87.
88. El-Husseini AE, Vincent SR. 1999. Cloning and characterization of a novel RING finger protein that interacts with class V myosins. J Biol Chem 274:19771-19777.
89. Skurat AV, Dietrich AD, Zhai L, Roach PJ. 2002. GNIP, a novel protein that binds and activates glycogenin, the self-glucosylating initiator of glycogen biosynthesis. J Biol Chem 277:19331-19338.
90. Harada H, Harada Y, O'Brien DP, Rice DS, Naeve CW, et al. 1999. HERF1, a novel hematopoiesis-specific RING finger protein, is required for terminal differentiation of erythroid cells. Mol Cell Biol 19:3808-3815.
91. Hirose S, Nishizumi H, Sakano H. 2003. Pub, a novel PU.1. binding protein, regulates the transcriptional activity of PU.1. Biochem Biophys Res Commun 311:351-360.
92. Beer HD, Munding C, Dubois N, Mamie C, Hohl D, et al. 2002. The estrogen-responsive B box protein: a novel regulator of keratinocyte differentiation. J Biol Chem 277:20740-20749.
93. Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, et al. 2003. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell 11:591-604.
94. Ishii T, Ohnuma K, Murakami A, Takasawa N, Yamochi T, et al. 2003. SS-A/Ro52, an autoantigen involved in CD28-mediated IL-2 production. J Immunol 170:3653-3661.
95. Friedman JR, Fredericks WJ, Jensen DE, Speicher DW, Huang XP, et al. 1996. KAP-1, a novel corepressor for the highly conserved KRAB repression domain. Genes Dev 10:2067-2078.
96. Gammas F, Mark M, Dolle P, Dierich A, Chambon P, et al. 2000. Mice lacking the transcriptional corepressor TIF1beta are defective in early postimplantation development. Development 127:2955-2963.
97. Kapp LN, Painter RB, Yu LC, van Loon N, Richard CW 3rd, et al. 1992. Cloning of a candidate gene for ataxia-telangiectasia group D. Am J Hum Genet 51:45-54.
98. Kitamura K, Tanaka H, Nishimune Y. 2003. Haprin, a novel haploid germ cell-specific RING finger protein involved in the acrosome reaction. J Biol Chem 278:44417-44423.
99. Wang Y, Li Y, Qi X, Yuan W, Ai J, et al. 2004. TRIM45, a novel human RBCC/TRIM protein, inhibits transcriptional activities of EIK-1 and AP-1. Biochem Biophys Res Commun 323:9-16.
100. Shyu HW, Hsu SH, Hsieh-Li HM, Li H. 2003. Forced expression of RNF36 induces cell apoptosis. Exp Cell Res 287:301-313.
101. Spencer JA, Eliazer S, Ilaria RL Jr, Richardson JA, Olson EN. 2000. Regulation of microtubule dynamics and myogenic differentiation by MURF, a striated muscle RING-finger protein. J Cell Biol 150:771-784.
102. El-Hodiri HM, Shou W, Etkin LD. 1997. xnf7 functions in dorsal-ventral patterning of the Xenopus embryo. Dev Biol 190:1-17.
103. Slack FJ, Basson M, Liu Z, Ambras V, Horvitz HR, et al. 2000. The lin-41 RBCC gene acts in the C. elegans heterochronic pathway between the let-7 regulatory RNA and the LIN-29 transcription factor. Mol Cell 5:659-669.
104. Frank DJ, Roth MB. 1998. ncl-1 is required for the regulation of cell size and ribosomal RNA synthesis in Caenorhabditis elegans. J Cell Biol 140:1321-1329.
105. Arama E, Dickman D, Kimchie Z, Shearn A, Lev Z. 2000. Mutations in the beta-propeller domain of the Drosophila brain tumor (brat) protein induce neoplasm in the larval brain. Oncogene 19:3706-3716.
106. Sonoda J, Wharton RP. 2001. Drosophila Brain Tumor is a translational repressor. Genes Dev 15:762-773.